Home
Help
Coronavirus (COVID-19) Alerts and Registration
Alert Compliance Data
Other Safety Information
Login
Javascript is disabled because of the browser settings on this machine. So, a few features might not be available.
-
Search Alert Broadcasts (publicly issued alerts)
Reference:
Keyword:
Issue date:
From:
To:
Originator: (For multiple select: Ctrl key + Click)
CAS - Helpdesk - Team
CAS Helpdesk Team
CAS Helpdesk Team/Emergency
CAS-Helpdesk Team
CMO Messaging
Department of Health
DH Estates and Facilities
DH Estates and Facilities/National Patient Safety Agency
DH Supply Disruption
DHSC & NHS England and Improvement: Supply disruption alert
DHSC Supply Disruption Alert
Medical Devices Safety Bulletin
MHRA Dear Doctor Letter
MHRA Drug Alerts
MHRA Medical Device Alerts
National Institute for Health and Clinical Excellence/National Patient Safety Agency
National Patient Safety Agency
National Patient Safety Alert - MHRA
National Patient Safety Alert - NHS England & NHS Improvement
National Patient Safety Alert - Public Health England
National Patient Safety Alert - UKHSA
NHS Blood and Transplant
NHS Digital
NHS England
NHS England and NHS Improvement Estates and Facilities
NHS England Operations and Information Directorate – National Primary Care Commissioning Team
NHS Estates
NHS Improvement
NHS Improvement Estates and Facilities
NHS Improvement Estates and Facilities
Others
SHOT - Serious Hazards of Transfusion
Testing-08-April
Reference
Alert Title
Originated By
Issue Date
Status
SHOT/2022/001
Preventing transfusion delays in bleeding and critically anaemic patients
SHOT - Serious Hazards of Transfusion
17-Jan-2022
Issued
CEM/CMO/2021/023
Neutralising monoclonal antibody and intravenous antiviral treatments for patients in hospital with ...
CMO Messaging
24-Dec-2021
Issued
SDA/2021/016
Advanz epoprostenol 0.5mg and 1.5mg powder and solvent (pH10.5) solution for infusion vials - Supply ...
DHSC & NHS England and Improvement: Supply disruption alert
21-Dec-2021
Issued
CEM/CMO/2021/022
Neutralising monoclonal antibodies in the treatment of COVID-19 in hospitalised patients
CMO Messaging
16-Dec-2021
Issued
CEM/CMO/2021/021
Neutralising monoclonal antibodies (nMABs) or antivirals for non-hospitalised patients with COVID-19
CMO Messaging
16-Dec-2021
Issued
CEM/CMO/2021/011(U)
Withdrawal of the Recommendation for Consideration of Inhaled Budesonide as a Treatment Option for C ...
CMO Messaging
14-Dec-2021
Issued
CEM/CMO/2021/020
Neutralising monoclonal antibodies (nMABs) or antivirals for non-hospitalised patients with COVID-19
CMO Messaging
08-Dec-2021
Issued
CEM/CMO/2021/019
Update on COVID-19 Variant B.1.1.529
CMO Messaging
28-Nov-2021
Issued
SDA/2021/015
Hypovase (prazosin) 500 microgram tablets - Supply disruption
DHSC & NHS England and Improvement: Supply disruption alert
25-Nov-2021
Issued
NatPSA/2021/010/UKHSA
The safe use of ultrasound gel to reduce infection risk
National Patient Safety Alert - UKHSA
11-Nov-2021
Issued
1
2
3
4
5
6
7
8
9
10
...
* Alerts highlighted in blue are National Patient Safety Alerts. Further information about this type of alert
can be found in this update.
Contact our helpdesk
Email:
safetyalerts@mhra.gov.uk